View all services

01 July 2019 • Articles

Morrow Sodali

Pfizer Inc. (NYSE: PFE) to acquire Array BioPharma Inc. (NASDAQ: ARRY)

Pfizer Inc. (NYSE:PFE) and Array BioPharma Inc. (NASDAQ: ARRY) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array. Pfizer has agreed to acquire Array for $48 per share in cash, for a total enterprise value of approximately $11.4 billion.

Morrow Sodali is serving as the information agent for this transaction.

Download the pdf to see the Wall Street Journal ad.

For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.